Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-25

Clinical Trial Update: Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF [NA]

View source ↗

Summary

A prospective randomized trial comparing late-start versus standard-start corifollitropin alfa for IVF in poor, normal, and high responders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elonva (corifollitropin alfa)

Snippet

Sponsor: University of Turin, Italy | Conditions: Fertility Disorders | NA | Status: COMPLETED